Clinical trial
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to…
NCT00125606 · University Hospital Muenster, Other · Terminated
Key facts
| NCT number | NCT00125606 |
|---|---|
| Title | Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide |
| Official title | Randomized Phase 3 Trial for Patients With AML in CR2 Comparing Total Body Irradiation (TBI) With 8Gy/Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Technische Universität Dresden Philipps University Marburg Universitätsklinikum Hamburg-Eppendorf Hannover Medical School Ludwig-Maximilians - University of Munich University Hospital, Essen Johann… |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Procedure |
| Interventions | conditioning for allogeneic HSCT |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Aug 1, 2005 |
| Last update posted | Dec 18, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: